212 related articles for article (PubMed ID: 17038868)
1. Sirolimus--challenging current perspectives.
Buhaescu I; Izzedine H; Covic A
Ther Drug Monit; 2006 Oct; 28(5):577-84. PubMed ID: 17038868
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus: its role in nephrology.
Lee VW; Chapman JR
Nephrology (Carlton); 2005 Dec; 10(6):606-14. PubMed ID: 16354246
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus in renal transplantation.
Morath C; Arns W; Schwenger V; Mehrabi A; Fonouni H; Schmidt J; Zeier M
Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii61-viii65. PubMed ID: 17890266
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus-based immunosuppression: present state of the art.
Kahan BD
J Nephrol; 2004; 17 Suppl 8():S32-9. PubMed ID: 15599884
[TBL] [Abstract][Full Text] [Related]
5. Considerations in sirolimus use in the early and late post-transplant periods.
Patel SJ; Elliott EN; Knight RJ; Gaber LW; Gaber AO
Expert Opin Drug Saf; 2009 Jul; 8(4):421-34. PubMed ID: 19522662
[TBL] [Abstract][Full Text] [Related]
6. Cardiac tamponade in a pediatric renal transplant recipient on sirolimus therapy.
Truong U; Moon-Grady AJ; Butani L
Pediatr Transplant; 2005 Aug; 9(4):541-4. PubMed ID: 16048611
[TBL] [Abstract][Full Text] [Related]
7. Fifteen years of clinical studies and clinical practice in renal transplantation: reviewing outcomes with de novo use of sirolimus in combination with cyclosporine.
Kahan BD
Transplant Proc; 2008 Dec; 40(10 Suppl):S17-20. PubMed ID: 19100899
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of adverse events requiring suspension of mTOR inhibitors: everolimus versus sirolimus.
Sánchez-Fructuoso AI; Ruiz JC; Pérez-Flores I; Gómez Alamillo C; Calvo Romero N; Arias M
Transplant Proc; 2010 Oct; 42(8):3050-2. PubMed ID: 20970607
[TBL] [Abstract][Full Text] [Related]
9. [Nephrotoxicity of sirolimus: experimental and clinical data].
Pallet N; Thervet E; Legendre C; Anglicheau D
Nephrol Ther; 2006 Sep; 2(4):183-90. PubMed ID: 16966063
[TBL] [Abstract][Full Text] [Related]
10. [Side effects of proliferation signal inhibitors and their management].
Epailly E; Lorho R
Gastroenterol Clin Biol; 2009 Nov; 33 Suppl 4():S268-74. PubMed ID: 20004334
[TBL] [Abstract][Full Text] [Related]
11. Angioedema in renal transplant recipients on sirolimus.
Mahé E; Morelon E; Lechaton S; Kreis H; de Prost Y; Bodemer C
Dermatology; 2007; 214(3):205-9. PubMed ID: 17377381
[TBL] [Abstract][Full Text] [Related]
12. Benefit-risk assessment of sirolimus in renal transplantation.
Kuypers DR
Drug Saf; 2005; 28(2):153-81. PubMed ID: 15691225
[TBL] [Abstract][Full Text] [Related]
13. The role and value of sirolimus administration in kidney and liver transplantation.
Mehrabi A; Fonouni H; Kashfi A; Schmied BM; Morath Ch; Sadeghi M; Schemmer P; Encke J; Sauer P; Zeier M; Weitz J; Büchler MW; Schmidt J
Clin Transplant; 2006; 20 Suppl 17():30-43. PubMed ID: 17100699
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors.
Di Benedetto F; Di Sandro S; De Ruvo N; Spaggiari M; Montalti R; Ballarin R; Cappelli G; Gerunda GE
J Clin Gastroenterol; 2009 Mar; 43(3):280-6. PubMed ID: 19057397
[TBL] [Abstract][Full Text] [Related]
15. Azoospermia in a renal transplant recipient during sirolimus (rapamycin) treatment.
Skrzypek J; Krause W
Andrologia; 2007 Oct; 39(5):198-9. PubMed ID: 17714220
[TBL] [Abstract][Full Text] [Related]
16. [Use of Sirolimus in five pediatric patients undergoing solid organ transplantation].
Roque E J; Ríos M G; Vignolo A P; Pinochet V C; Schultz M; Humeres A R; Delucchi A; Rius A M; Hepp K J
Rev Med Chil; 2008 May; 136(5):631-6. PubMed ID: 18769812
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium xenopi pulmonary infection in two renal transplant recipients under sirolimus therapy.
Thaunat O; Morelon E; Stern M; Buffet P; Offredo C; Mamzer-Bruneel MF; Kreis H
Transpl Infect Dis; 2004 Dec; 6(4):179-82. PubMed ID: 15762936
[TBL] [Abstract][Full Text] [Related]
18. Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients.
Tenderich G; Fuchs U; Zittermann A; Muckelbauer R; Berthold HK; Koerfer R
Clin Transplant; 2007; 21(4):536-43. PubMed ID: 17645716
[TBL] [Abstract][Full Text] [Related]
19. Interstitial pneumonitis associated with sirolimus in liver transplantation: a case report.
Pérez MJ; Martín RO; García DM; Rey JM; de la Cruz Lombardo J; Rodrigo López JM
Transplant Proc; 2007 Dec; 39(10):3498-9. PubMed ID: 18089419
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic role of sirolimus in non-transplant kidney disease.
Rangan GK; Nguyen T; Mainra R; Succar L; Schwensen KG; Burgess JS; Ho KO
Pharmacol Ther; 2009 Aug; 123(2):187-206. PubMed ID: 19374918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
